Last reviewed · How we verify

NCT07373119: FRAGICOR

Improving Frailty in Patients With Stable Ischemic Heart Disease

ENROLLING BY INVITATION NA Last updated 28 January 2026
What this trial tests

NA trial testing physiotherapy in Coronary Heart Disease in 60 participants. Enrolling by invitation.

Timeline
1 October 2025
Primary endpoint
30 December 2025
31 December 2026

Quick facts

Lead sponsorFundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment60
Start date1 October 2025
Primary completion30 December 2025
Estimated completion31 December 2026
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina — full company profile →

Who can join

70 and older, any sex, with Coronary Heart Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to improve the frailty in old patients who have a cardiac disease . Researchers will determine the improvement in the instability and the strength along twelve sessions based on guided exercises and mobility techniques made by physiotherapists. Research team will also evaluate the medications and diet, as well as laboratory and clinical tests.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of physiotherapy

Trials testing the same drug.

Other recruiting trials for Coronary Heart Disease

Currently open trials in the same condition.

Other Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07373119.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing